
Venus Medtech Investor Relations Material
Latest events

H1 2025
28 Aug, 2025

H2 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Venus Medtech (Hangzhou) Inc
Access all reports
Venus Medtech Inc. is a medical device company focused on the development and commercialization of transcatheter heart valve products for structural heart diseases. The company's diverse product portfolio encompasses solutions such as the VenusA-valve and VenusP-valve, alongside other devices aimed at addressing conditions related to aortic stenosis and pulmonic, mitral, and tricuspid regurgitation. Venus Medtech has established itself as a leader in the field by continuously focusing on innovations in new materials, bionics, image fusion techniques, and digital sensing to meet the evolving needs of doctors and patients globally. The company is headquartered in Hangzhou, China, and its shares are listed on the Hong Kong Stock Exchange.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
2500
Country
🇭🇰 Hong Kong